Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows (Unaudited)

v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Loss from continuing operations $ (1,856,111) $ (741,090)  
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:      
Depreciation and amortization 1,195,751 40,957  
Noncash lease expense 22,847 22,848  
Stock-based compensation expense 30,822 36,641  
Provision for doubtful accounts (14,908) 9,663 $ 142,618
Unrealized loss on investment 0 44,000  
Loss on disposal of property, plant and equipment 18,507 0  
Changes in operating assets and liabilities, net of effects of discontinued operations:      
Accounts receivable 98,697 77,223  
Prepaid expenses and other current assets 162,165 (69,814)  
Accounts payable 125,859 271,042  
Accrued expenses 25,408 (4,136)  
Other current liabilities (28,968) 0  
Lease liability (27,574) (26,961)  
Deferred revenue (114,741) 55,496  
Net cash used in operating activities (362,246) (284,131)  
Cash flows from investing activities:      
Costs incurred to develop technology 0 0  
Purchases of property and equipment 0 0  
Payments to acquire investments 0 (1,300,000)  
Purchases of intangible assets 0 0  
Net cash used in investing activities 0 (1,300,000)  
Cash flows from financing activities:      
Proceeds from the sale of common stock 1,205,000 349,413  
Proceeds from (Repayment of) short-term debt 180,000 0  
Proceeds from Noncontrolling Interests 0 0  
Net cash provided by (used in) financing activities 1,385,000 349,413  
Net decrease in cash and cash equivalents 1,022,754 (1,234,718)  
Cash, cash equivalents, beginning of period 1,466,954 1,731,155 1,731,155
Cash and cash equivalents, end of period 2,489,708 496,437 $ 1,466,954
Supplemental disclosures of other cash flow information:      
Cash paid for income taxes 0 0  
Non-cash amortization of commitment funding 0 187,500  
Stock for Acquired DDT tokens [Member]      
Supplemental disclosures of other cash flow information:      
Non-cash stock issuance 2,593,780 0  
Conversion of Note Payable into Common Stock [Member]      
Supplemental disclosures of other cash flow information:      
Conversion from Note Payable to common stock 74,630 0  
Remote More [Member]      
Supplemental disclosures of other cash flow information:      
Non-cash stock issuance 0 300,000  
Capitalized Technology [Member]      
Supplemental disclosures of other cash flow information:      
Non-cash stock issuance $ 119,990 $ 0